Navigation Links
Life Technologies Chairman And CEO Gregory T. Lucier Named Penn State Outstanding Engineering Alumnus
Date:4/5/2013

UNIVERSITY PARK, Pa., April 5, 2013 /PRNewswire/ -- Gregory T. Lucier, Chairman and CEO of Life Technologies in Carlsbad, Calif, has been named an Outstanding Engineering Alumnus by the Penn State College of Engineering in recognition of his exceptional professional achievements.

Established in 1966, the award is the highest honor the College bestows on its alumni. Lucier will be honored during a ceremony at the Nittany Lion Inn in State College on April 9.

A 1986 graduate of Penn State with a bachelor's degree in industrial engineering, Lucier fosters a culture of excellence at Life Technologies, a global biotechnology company with a presence in more than 180 countries and had sales of $3.8 billion in 2012. Ranked 9th among the world's 50 most innovative companies, Life Technologies is a market leader in products and services that accelerate advancements in basic research and drug development, molecular diagnostics, 21st century forensics, regenerative science and agricultural research. Today, he applies his more than 25 years of strategic management experience in his endeavor to shape an era of personalized medicine in which researchers can efficiently read, write and edit DNA for humanity's benefit.

After completing his M.B.A. at Harvard Business School, Lucier served in a variety of leadership roles at General Electric (GE) Corporation, including president and CEO of GE Medical Systems Information Technologies. After joining Invitrogen Corporation in 2003, a leading supplier of life sciences research tools, he led the 2008 merger between the company and Applied Biosystems, a deal valued at more than $6.5 billion that formed Life Technologies Corporation. Today, Lucier is driven to change the face of healthcare and with a vision to see genomic-based medicine implemented to guide targeted treatments of human disease in the near future.    

Lucier also serves on the Board of Directors at Synthetic Genomics, Inc., CareFusion Corporation, Rady Children's Hospital and the California Healthcare Institute. 

Contact:
Stefanie Tomlinson
Phone: 814-865-9031
E-mail: news@engr.psu.edu


'/>"/>
SOURCE The Pennsylvania State University
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):